PRKN and Parkinson disease: Several studies suggest that loss of function mutations in the PRKN gene that encodes the Parkin may promote α-synuclein-mediated Lewy body inclusion formation, further suggesting the importance of studying this target as a biomarker of PD (Madsen et al., 2021; Yasuda and Mochizuki, 2010).